1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 18th March 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Neuropsychiatry’s Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research, 2022,Baslet

Discussion in 'Psychosomatic research - ME/CFS and Long Covid' started by Andy, May 18, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    21,810
    Location:
    Hampshire, UK
    [Almost all of the authors have been authors on pro-FND papers previously]

    Abstract

    The postacute sequelae of COVID-19 infection (PASC), also known as post-COVID condition or “long COVID,” refers to symptoms that persist after the initial acute phase of the infection. PASC symptoms may occur in patients who had mild acute disease. On the basis of current data, commonly reported neurological and psychiatric symptoms in PASC include sleep problems, fatigue, cognitive impairment, headache, sensorimotor symptoms, dizziness, anxiety, irritability, and depression. Knowledge from neuropsychiatric sequelae of other viral infections, such as other coronaviruses, provides us with information about the heterogeneity and similarities of neuropsychiatric clinical presentations that may follow viral illnesses over a long period. Several, possibly overlapping, pathophysiological mechanisms have been proposed to explain neuropsychiatric PASC: direct effects of the virus and immunological, vascular, functional, iatrogenic, and other etiologies.

    The authors present practice considerations for clinicians confronted with the challenge of evaluating and treating patients who have neuropsychiatric PASC. A comprehensive neuropsychiatric approach reviews historical factors, provides an objective assessment of symptoms, carefully considers all potential etiologies, and offers a therapeutic approach aimed at restoring premorbid functioning. Given the currently limited therapeutic options for neuropsychiatric PASC, unless an alternative etiology is identified, treatment should be symptom based and guided by evidence as it emerges.

    Paywall, https://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.21080209
     
  2. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,299
    Location:
    Canada
    Ah, well, nevertheless. It sure would have been nice to have those by now. But I guess pretending those exist should keep working for a while, at least as long as no one expects anything out of this specialty.
    How could we possibly pass on the opportunity of using "have you tried not thinking about being ill?" as a safe and effective treatment for "patient has nothing wrong, should not be here".

    The initial reaction to Long Covid was a strongly assertive: impossible. That's how much they know and understand the sequelae from other viral infections. This is rewriting the recent past, as if it didn't happen the way it did, instead the way they prefer it could have happened, if they had not selected to simply not do the work.

    Orwell would actually spin in his grave out of this, maybe we can consider tapping this as an infinite energy source?
     

Share This Page